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Abstract: Glutathione synthetases catalyze the  ATP-dependent synthesis of glutathione 
from L-γ-glutamyl-L-cysteine and glycine. Although these enzymes have been sequenced 
and characterized from a variety of biological sources, their exact catalytic mechanism is 
not  fully  understood  and  nothing  is  known  about  their  adaptation  at  extremophilic 
environments. Glutathione synthetase from the Antarctic eubacterium Pseudoalteromonas 
haloplanktis  (PhGshB)  has  been  expressed,  purified  and  successfully  crystallized.  An 
overall  improvement  of  the  crystal  quality  has  been  obtained  by  adapting  the  crystal 
growth conditions found with vapor diffusion experiments to the without-oil microbatch 
method. The best crystals of PhGshB diffract to 2.34 Å resolution and belong to space 
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group  P212121,  with  unit-cell  parameters  a  =  83.28  Å,  b  =  119.88  Å,  c  =  159.82  Å. 
Refinement of the model, obtained using phases derived from the structure of the same 
enzyme  from Escherichia coli  by  molecular replacement,  is  in progress.  The structural 
determination  will  provide  the  first  structural  characterization  of  a  psychrophilic 
glutathione synthetase reported to date.  
Keywords: crystal quality; without-oil microbatch; glutathione synthetase; psychrophile; 
X-ray crystallography 
 
1. Introduction  
The  tripeptide  glutathione  (GSH)  is  the  most  abundant  antioxidant  molecule  in  cells  and  has 
multiple biological functions. Besides its protective role in counteracting oxidative free radical species 
and in the removal of toxic metals, GSH is involved in redox homeostasis, amino acid transport and 
metabolism of therapeutic drugs, mutagenesis and carcinogenesis; in addition, GSH is also involved in 
cell cycle regulation, cell signaling, and apoptosis [1–3]. The synthesis of GSH from its constituent 
amino  acids  L-glutamic  acid,  L-cysteine  and  glycine  involves  two  ATP-requiring  enzymatic  steps 
catalyzed  by  glutamate  cysteine  ligase  (GshA)  and  glutathione  synthetase  (GshB),  respectively.  
In particular, glutathione synthetase catalyzes the synthesis of GSH from the γ-L-glutamyl-L-cysteine 
and glycine in the presence of ATP and magnesium ion [4]. This process involves the formation of  
an acyl phosphate on the cysteinyl moiety in L-γ-glutamyl-L-cysteine, followed by the attack of the 
glycine and formation of an enzyme-product complex, which finally dissociates with the release of 
GSH, ADP and phosphate (1). 
L-γ-glutamyl-L-cysteine + glycine + ATP → GSH + ADP + Pi  (1) 
Glutathione  synthetase  has  been  purified,  sequenced  and  characterized  from  different  sources, 
including yeast [5], human [6,7], rat [8] and Escherichia coli [9]. The comparison of human enzyme 
with other eukaryotic proteins reveals a high sequence variability, with identity ranging from 18% to 
69% [10]. To date, glutathione biosynthesis has never been studied in a psychrophilic source, even 
though it is known that some antioxidant proteins are covalently modified and likely regulated by 
cellular thiols (see for example [11–13]). 
Pseudoalteromonas  haloplanktis,  a  psychrophilic  Gram-negative  bacterium  collected  from 
Antarctic  seawater  (growth  temperature  interval,  4–20  °C),  produces  a  glutathione  synthetase 
(PhGshB), whose polypeptide chain is made up of 315 residues, corresponding to a molecular mass of 
36 kDa. Sequence alignments show a significant similarity of PhGshB with its mesophilic counterpart 
from E. coli (69% sequence identity), whose structure has been already determined [14,15]. With the 
aim of gaining insights on the mechanism of cold adaptation of glutathione synthetases and to shed 
light on the exact mechanism of catalytic action of these enzymes, we have undertaken the structural 
and functional characterization of PhGshB. In this article, we describe the expression, purification, 
crystallization and preliminary X-ray diffraction studies of the protein. We found that the adaptation of Int. J. Mol. Sci. 2011, 12                       
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crystallization conditions found using vapor diffusion experiments to a modified microbatch method 
significantly improves the size and the diffracting power of PhGshB crystals. 
2. Results and Discussion  
2.1. Crystallization of PhGshB 
A recombinant form of PhGshB (rPhGshB) with the C-terminal lysine replaced by the extrapeptide 
Leu-Glu-His6-tag,  LE(H)6,  has  been  successfully  expressed,  purified  and  crystallized  using  
vapor-diffusion and small-scale batch (microbatch) methods. The purified rPhGshB showed a single 
band  of  approximately  36  kDa  on  SDS-PAGE,  which  is  in  good  agreement  with  the  theoretical 
molecular mass predicted by the amino acid sequence. Initial screenings using commercially available 
solutions (Crystal Screen kits I and II, and Index kit from Hampton Research, Laguna Niguel, USA, 
www.hamptonreaserch.com) revealed several promising conditions for the crystallization of rPhGshB. 
All favorable conditions were characterized by the presence of polyethylene glycol as precipitating 
agent. In particular, cubic and rod-like crystals appeared within 2–5 days using a 20 mg mL
−1 protein 
concentration  in  the  hanging-drop  method  from  crystallization  conditions  with  the  reservoir  
solution  containing  30%  w/v  MPEG  2K,  0.1  M  potassium  thiocyanate,  and  25%  w/v  PEG  3350,  
0.1 M HEPES pH 7.5, respectively. At this stage, maximum size of cubic crystals (Figure 1a) was  
0.05 mm × 0.05 mm × 0.04 mm, whereas that for rod-like crystals was 0.1 mm × 0.1 mm × 0.2 mm. 
The  quality  of  the  crystals  was  improved  by  fine-tuning  the  concentration  of  protein  
(10.0–30.0  mg  mL
−1)  and  precipitants  and  evaluating  the  effect  of  several  salts,  like  ammonium 
sulfate,  sodium  malonate,  sodium  potassium  tartrate  and  tacsimate.  The  best  crystals  (rod-like,  
Figure  1b)  were  obtained  from  a  crystallization  solution  containing  10%  w/v  PEG  20K,  5%  v/v 
tacsimate and 0.1 M HEPES pH 7.5 and rPhGshB at 20.0 mg mL
−1. 
Figure 1. Image of typical cubic (a) and rod-like (b) rPhGshB crystals grown by vapor 
diffusion; (c) crystals grown by without-oil microbatch technique. 
     
(a)  (b)  (c) 
Preliminary X-ray diffraction data showed that cubic crystals are intrinsically disordered and that 
the  largest rod-like  crystals  obtained  by  vapor  diffusion  diffract  at  most  at  3.5  Å  resolution,  they 
belong to the space group P212121, with unit-cell parameters a = 82.81 Å, b = 119.94 Å, c = 159.32 Å. 
Further optimization of the crystallization conditions to grow larger and thicker crystals suitable for 
diffraction  data  collection  at  high  resolution  were  performed  using  the  microbatch  method.  This 
procedure consists of slowly and thoroughly mixing the precipitant with the protein and then placing Int. J. Mol. Sci. 2011, 12                       
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the mixture in a well-sealed container. Usually the drop is incubated under silicon oil to prevent too 
rapid dehydration [16]. The benefits of microbatch have been well documented [16,17]. In the present 
case, a modified microbatch method, that we define without-oil microbatch, has been used: the drop is 
stored in the presence of a reservoir with the same precipitant concentration, to avoid drop evaporation [18]. 
A similar microbatch technique, which does not utilize oil (Small-Scale Batch without Oil) has been 
developed at the University of Wisconsin [19], and has been successfully used for many years, though 
no claim is made for its originality. As reported in other cases [18,19], we found that crystallization 
occurred  using  60%–80%  of  the  concentration  of  the  precipitant  required  in  the  hanging  drop 
experiment. The best crystals of rPhGshB (maximum size of 0.2  mm × 0.3  mm × 0.4 mm) were 
obtained  by  mixing  a  solution  containing  14%  w/v  PEG  20K,  0.2  M  HEPES  pH  7.5,  10%  v/v 
tacsimate with an equal volume of protein solution at 40 mg mL
−1 (Figure 1c). These crystals diffract 
to  2.34  Å  resolution  and  are  isomorphous  to  those  obtained  by  hanging  drop  experiments,  with  
unit-cell  parameters  a  =  83.28  Å,  b  =  119.88  Å,  c  =  159.82  Å  (Table  1).  Matthews  coefficient 
calculations suggested the presence of  four chains of rPhGshB (VM = 2.79 Å
3 Da
−1,  56% solvent 
content [20]) in the asymmetric unit. The application of the molecular replacement, as detailed in the 
Experimental Section, allowed the identification of orientation and position of the four chains in the 
asymmetric unit that gave a satisfactory fit of the experimental data. Rebuilding and refinement of the 
whole structure is in progress. Calculated preliminary (Fo-Fc) and (2Fo-Fc) difference Fourier maps are 
of excellent quality. 
Table 1. X-ray diffraction data collection statistics. 
  rPhGshB 
Space group  P212121 
Cell parameters:   
a (Å)  83.28 
b (Å)  119.88 
c (Å)  159.82 
Resolution limits (Å)  50.00–2.34 
Highest resolution shell (Å)  2.45–2.34 
No. of observations  337677 
No. of unique reflections  66744 
Completeness (%)  97.1 (85.0) 
I/ (I)  20.5 (2.6) 
Average multiplicity  5.1 (2.5) 
Rmerge (%)  11.5 (40.5) 
Rpim  5.0 (27.5) 
Rrim  12.7 (49.6) 
Mosaicity  0.3 
Note: Values in parentheses correspond to the highest resolution shells. Int. J. Mol. Sci. 2011, 12                       
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3. Experimental Section 
3.1. Expression and Purification of rPhGshB 
The  putative  gene  encoding  GshB  in  P.  haloplanktis  (PhgshB;  ID  3708001)  [21]  was  
amplified  by  PCR  using  specific  oligonucleotides  allowing  its  cloning  in  the  pET-28a(+)  vector.  
The  forward  and  reverse  primers  used  were  5′d–A–12AGGCACAGCCC•ATG•GCA•ATT9–3′  and  
5′d–A960AC•GCT•AAC•CTC•GAG•AGC•GAG•TCG•T936–3′,  respectively.  Numbering  in  primers 
begins  from  starting  codon  (italics),  whereas  underlined  letters  indicate  mismatches  introduced  to 
create the NcoI and XhoI restriction sites. The amplified segment was digested with NcoI and XhoI and 
cloned  in  pET-28a(+)  previously  digested  with  the  same  endonucleases.  The  new  construct  was 
controlled by nucleotide sequencing and used to transform the E. coli BL21(DE3) strain. A culture of 
this transformant was grown at 37 °C up to 0.6 OD600 and the heterologous expression was induced for 
2 h upon the addition of 0.1 mg mL
−1 isopropyl--thiogalactopyranoside. Bacterial cells were collected 
by centrifugation, resuspended in 20 mM Tris-HCl buffer pH 7.8, and then lysed by a French Press 
(Aminco, USA) to obtain a cell homogenate. This sample was then centrifuged at 30,000 × g for 1 h 
and the supernatant was used as starting material for the purification by affinity chromatography on 
Ni-NTA agarose of rPhGshB, which had the C-terminal lysine replaced by the extrapeptide LE(H)6. 
To this aim, the supernatant was added in batch to the Ni-NTA Agarose resin, equilibrated in 20 mM 
Tris-HCl buffer pH 7.8. After incubation overnight at 4 °C, the slurry was poured in a column, which 
was extensively washed with the same buffer supplemented with 10 mM imidazole-HCl. The bound 
rPhGshB was then eluted with 20 mM Tris-HCl buffer pH 7.8 supplemented with 50 mM imidazole-HCl 
and  pure  protein  fractions,  as  analysed  by  SDS-polyacrylamide  gel  elecrophoresis,  were  pooled 
together,  concentrated  by  ultrafiltration,  and  stored  at  −20  °C  in  20  mM  Tris-HCl  buffer  pH  7.8 
supplemented with 50% (v/v) glycerol. Nearly 20 mg of pure rPhGshB were obtained from a 1 L 
culture of the transformant. 
3.2. Crystallization of rPhGshB 
Purified rPhGshB was concentrated to 40 mg mL
−1 in 20 mM Tris-HCl pH 7.8. Crystallization was 
performed at 20 °C by the hanging-drop vapor-diffusion method with 0.2 µL of protein and 0.2 µL of 
reservoir. The following commercially available screens were used: Crystal Screen kits I and II, and 
Index kit from Hampton Research. 
Optimization  of  the  crystallization  conditions  was  performed  by  fine-tuning  the  protein  and 
precipitant concentrations using a drop consisting of 0.5 µL protein solution and 0.5 µL precipitant 
solution and a reservoir volume of 500 µL. 
Cubic crystals were obtained within 2–5 days from drops containing rPhGshB (20 mg mL
−1 in  
10 mM Tris-HCl pH 7.8) 30% w/v MPEG 2K and 0.1 M potassium thiocyanate, whereas rod-like 
crystals were obtained using the same protein solution and a precipitant solution containing 25% w/v 
PEG 3350 and 0.1 M HEPES pH 7.5. An improvement in the quality of crystals was obtained using 
different salts and precipitant agents. In particular, well-shaped crystals were grown using 10% w/v 
PEG 20K, 5% v/v tacsimate, 0.1 M HEPES pH 7.5 as a precipitant solution. However, these crystals 
only  diffract  at  3.5  Å  resolution.  A  further  improvement  was  obtained  adopting  the  without-oil Int. J. Mol. Sci. 2011, 12                       
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microbatch method. In this technique, a solution of 40 mg mL
−1 protein in 20 mM Tris-HCl pH 7.8 
was  directly  mixed  with  an  equal  amount  of  precipitating  solution  (final  concentration:  7%  w/v 
PEG20K, 5% v/v tacsimate, 0.1 M HEPES pH 7.5). In all the experiments, standard 24-well linbro 
plates (Hampton Research, Laguna Niguel, USA, www.hamptonreaserch.com) have been used.  
3.3. Data collection and Processing 
Preliminary diffraction data (3.5 Å resolution) on the rod-like crystals obtained by vapor diffusion 
were collected at the Institute of Biostructures and Bioimages (Naples, Italy), at 100 K using a Rigaku 
MicroMax-007 HF generator producing Cu Kα radiation and equipped with a Saturn944 CCD detector. 
Higher resolution data (2.34 Å) were collected at 100 K on the crystals obtained by without-oil 
microbatch at the synchrotron beamline XRD1 of Elettra (Trieste, Italy). Cryoprotection of the crystals 
was achieved by rapid soaking (1–2 s) in a solution consisting of 12% w/v PEG 20K, 0.1 M HEPES 
buffer pH 7.5, 5% v/v tacsimate, 30% v/v glycerol. An oscillation range of 0.5° and an X-ray dose 
corresponding to about 5 s exposure were adopted for all experiments. The data sets were indexed, 
processed and scaled using the HKL-2000 program package (Table 1) [22]. The precision-indicating 
merging R-factors (Rpim and Rrim) were calculated using the program RMERGE [23,24]. 
3.4. Structure Determination 
The structure of the enzyme was solved by molecular replacement techniques using the program 
Phaser [25] and the single chain structure of GshB from E. coli as search model (PDB code 1GSA [14]). 
To avoid bias, ligands and water molecules were removed from the model prior to structure factors and 
phases calculation. The solution had an R-factor of 0.39. 
4. Conclusions 
In the current study, the glutathione synthetase from the Antarctic eubacterium Pseudoalteromonas 
haloplanktis was crystallized, X-ray diffraction data collected and the phase problem solved. 
An  overall  improvement  of  the  crystal  quality  was  obtained  by  adapting  the  crystal  growth 
conditions found with vapor diffusion experiments to the without-oil microbatch method. In general, 
the more stable the system in the crystallization process, the higher is the quality of the crystals. These 
conditions  are  better realized  in  the  microbatch  method,  where  the  crystallization  components  are 
mixed to their final concentration at the beginning of the experiment. A significant drawback of the 
under-oil microbatch method is the slow evaporation of water from the crystallization drops resulting 
sometimes  in the formation of salt deposits that interfere with protein crystal growth.  Our results, 
together with recent literature data [18,19], suggest that the adaptation of crystallization conditions to 
without-oil microbatch method could be a general strategy to convert poorly diffracting crystals into 
diffraction-quality ones, but further studies are needed to test the validity of this hypothesis. 
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